JPRN-UMIN000038503已完成未知
Effect of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients - Effect of omarigliptin on glucose variability and oxidative stress in type 2 diabetes patients
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine0 个研究点目标入组 50 人开始时间: 2020年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)the use of steroids or anti-inflammatory drugs, 2)diabetic ketosis and coma within 3 months before the study, 3)severe infection, severe trauma, pre-and post-operation, 4)an estimated glomerular filtration rate are within 30mL/min/1.73m2, 5)malignancy, 6)pregnancy 7)Patients who are judged as inappropriate for inclusion by phsicians
研究者
相似试验
尚未招募
不适用
The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetestype 2 diabetesJPRN-UMIN000021815Department of Endoclinology, Gifu University Graduate School of Medicine10
已完成
不适用
Effect of semaglutide on glucose variability and oxidative stress in type 2 diabetes patientsJPRN-UMIN000042670Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine42
已完成
4 期
Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled studytype 2 diabetes mellitusJPRN-UMIN000005627Department of Medicine II, Hokkaido University Hospital40
已完成
不适用
The efficacy of omarigliptin in type 2 diabetic patientsJPRN-UMIN000026700Kawashima Hospital, Social Medical Corporation Kawashima Hospital Group41
招募中
不适用
Effect of oral semaglutide on glucose variability and oxidative stress in type 2 diabetes patientstype 2 diabetesJPRN-jRCT1031210620Ohara Makoto58